CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2022	Nov. 30, 2021
Cash flows from operating activities:
Net (loss) earnings	$ (3,816)	$ 3,531
Adjustments to reconcile net (loss) earnings to net cash provided by operating activities:
Depreciation and amortization	495	500
Deferred income taxes	(1,602)	164
Stock compensation expense	222	35
Earnings from equity method investments	(61)	(93)
Gain on previously held investment interests	0	(2,576)
Gain on sale of equity method investments	(969)	0
Other	(129)	95
Changes in operating assets and liabilities:
Accounts receivable, net	151	(127)
Inventories	(918)	(1,352)
Other current assets	(68)	(58)
Trade accounts payable	867	1,335
Accrued expenses and other liabilities	(269)	(399)
Income taxes	153	79
Accrued litigation obligations	6,494	0
Other non-current assets and liabilities	(58)	(36)
Net cash provided by operating activities	493	1,099
Cash flows from investing activities:
Additions to property, plant and equipment	(610)	(454)
Proceeds from sale-leaseback transactions	409	202
Proceeds from sale of other assets	2,068	0
Business, investment and asset acquisitions, net of cash acquired	(80)	(1,800)
Other	70	95
Net cash provided by (used for) investing activities	1,858	(1,958)
Cash flows from financing activities:
Net change in short-term debt with maturities of 3 months or less	22	937
Proceeds from debt	17	7,940
Payments of debt	(11)	(4,444)
Stock purchases	(150)	(154)
Proceeds related to employee stock plans, net	6	19
Cash dividends paid	(415)	(413)
Other	(69)	(7)
Net cash (used for) provided by financing activities	(599)	3,877
Effect of exchange rate changes on cash, cash equivalents, marketable securities and restricted cash	4	(20)
Changes in cash, cash equivalents, marketable securities and restricted cash:
Net increase in cash, cash equivalents, marketable securities and restricted cash	1,756	2,998
Cash, cash equivalents, marketable securities and restricted cash at beginning of period	2,558	1,270
Cash, cash equivalents, marketable securities and restricted cash at end of period	$ 4,314	$ 4,268